6 studies found for:    rFVIIIFc
Show Display Options
Rank Status Study
1 Not yet recruiting An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Biological: BIIB031 (rFVIIIFc)
2 Completed Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: rFVIIIFc
3 Completed
Has Results
Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A
Condition: Severe Hemophilia A
Interventions: Drug: Factor VIII (rFVIIIFc);   Drug: Advate®
4 Enrolling by invitation Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: rFVIIIFc
5 Recruiting Pharmacokinetics of BIIB031 at 2 Vial Strengths
Condition: Severe Hemophilia A
Intervention: Biological: BIIB031 (rFVIIIFc)
6 Active, not recruiting Study of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB 031, in Pediatric PTP Subjects With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: rFVIIIFc

Indicates status has not been verified in more than two years